Latest News & Articles
Browse all our latest news articles and stories
FAQ on Safe Pro Group Inc.'s Participation in U.S. Army's CFWE-M 2026 with SpotlightAI™
Safe Pro Group Inc. (NASDAQ: SPAI) will showcase its SpotlightAI™ platform at the U.S. Army's CFWE-M 2026 experiment, demonstrating AI-powered …
Trilogy Metals Inc.: A Comprehensive FAQ for Investors and Interested Parties
FAQ: McEwen Inc. Q2 2025 Results Conference Call
McEwen Inc. has scheduled a conference call for August 7, 2025, to discuss its Q2 financial results and project updates, offering investors direct …
FAQ: Insights from Menaka Thillaiampalam, CMO of Hitachi Digital Services
Understanding Randamu and the dcipher Network: A Comprehensive FAQ
FAQ: Summer Events at The Works in August
Main Event Taylor Grand Opening FAQ
FAQ: Nachawati Law Group's New Antitrust Practice
FAQ: Finding a Trustworthy HVAC Repair Service in Atlanta
FAQ on Advarra's Appointment of Brian Hart as Chief Technology Officer
Advarra has appointed Brian Hart as its new Chief Technology Officer to lead technology and product strategy, aiming to innovate and enhance clinical …
FAQ: Understanding Lightforce Braces at TG Orthodontics
FAQ on Noma Security's New Executive Appointments and Their Impact on AI Security
FAQ: Apex Epoxy Flooring's New Marble Epoxy Line in Jacksonville
FAQ on the Rental Market, Insurance Considerations, and Demand Drivers with Charles Goodwin
FAQ on Wearable Devices Ltd.'s Continuation Patent for Gesture and Voice-Control Interface
Wearable Devices Ltd. has secured a continuation patent for its gesture and voice-control interface, enhancing its neural interface technologies for …
FAQ on Intensity Therapeutics' $6.6 Million ATM Stock Sales and Its Implications
FAQ: Atlanta Property Group's Expansion into Charlotte's Industrial Market
Atlanta Property Group (APG) has expanded its industrial portfolio by acquiring an 80,000-square-foot distribution building in Charlotte, NC, …
FAQ on Intensity Therapeutics' $6.6 Million Funding and Its Implications
Intensity Therapeutics raised $6.6 million through an At-the-Market offering to advance its clinical trials for novel intratumoral cancer therapies, …
FAQ on Lantern Pharma's AI Tool for Predicting Blood-Brain Barrier Permeability
Lantern Pharma has introduced predictBBB.ai(TM), an AI tool with 94% accuracy in predicting blood-brain barrier permeability, addressing a major …
